ArticleEuropean journal of medical research2025

Evaluating dynamic contrast-enhanced MRI for differentiating HER2-zero, HER2-low, and HER2-positive breast cancers in patients undergoing neoadjuvant chemotherapy.

Yangling Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.